[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals in Europe

May 2020 | 61 pages | ID: P0F573F8D4AEN
MarketLine

US$ 350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Pharmaceuticals in Europe

SUMMARY

Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The European pharmaceuticals market had total revenues of $244,555.8m in 2019, representing a compound annual growth rate (CAGR) of 2.1% between 2015 and 2019.
  • Due to the mature nature of multiple markets in the region, growth has been limited within Europe. However, some countries such as Russia and Turkey have bucked this trend to achieve strong growth rates.
  • The German government’s decision to increase its focus on the use of generic medicines to reduce healthcare spending and maintain economic stability has resulted in decreasing volumes and a downward pricing pressure on existing drugs.
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Europe
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts
REASONS TO BUY
  • What was the size of the Europe pharmaceuticals market by value in 2019?
  • What will be the size of the Europe pharmaceuticals market in 2024?
  • What factors are affecting the strength of competition in the Europe pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Europe's pharmaceuticals market?
1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. Are there any threats towards leading players?

8 COMPANY PROFILES

8.1. Johnson & Johnson
8.2. F. Hoffmann-La Roche Ltd
8.3. Bayer AG
8.4. GlaxoSmithKline Plc
8.5. Novartis AG
8.6. Pfizer Inc.

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

LIST OF TABLES

Table 1: Europe pharmaceuticals market value: $ billion, 2015-19
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Europe pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Europe pharmaceuticals market share: % share, by value, 2019
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: F. Hoffmann-La Roche Ltd: key facts
Table 10: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 11: F. Hoffmann-La Roche Ltd: Key Employees
Table 12: Bayer AG: key facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: GlaxoSmithKline Plc: key facts
Table 16: GlaxoSmithKline Plc: Annual Financial Ratios
Table 17: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 18: GlaxoSmithKline Plc: Key Employees
Table 19: GlaxoSmithKline Plc: Key Employees Continued
Table 20: Novartis AG: key facts
Table 21: Novartis AG: Annual Financial Ratios
Table 22: Novartis AG: Annual Financial Ratios (Continued)
Table 23: Novartis AG: Key Employees
Table 24: Novartis AG: Key Employees Continued
Table 25: Pfizer Inc.: key facts
Table 26: Pfizer Inc.: Annual Financial Ratios
Table 27: Pfizer Inc.: Key Employees
Table 28: Pfizer Inc.: Key Employees Continued
Table 29: Europe size of population (million), 2015-19
Table 30: Europe gdp (constant 2005 prices, $ billion), 2015-19
Table 31: Europe gdp (current prices, $ billion), 2015-19
Table 32: Europe inflation, 2015-19
Table 33: Europe consumer price index (absolute), 2015-19
Table 34: Europe exchange rate, 2015-19

LIST OF FIGURES

Figure 1: Europe pharmaceuticals market value: $ billion, 2015-19
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Europe pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Europe, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Europe, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Europe, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2019
Figure 10: Europe pharmaceuticals market share: % share, by value, 2019


More Publications